Strengthening Families & Communities LLC’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.46K Buy
22
+6
+38% +$1.7K ﹤0.01% 442
2026
Q1
$4.46K Hold
16
﹤0.01% 457
2025
Q4
$4.85K Hold
16
﹤0.01% 275
2025
Q3
$4.49K Buy
+16
New +$4.35K ﹤0.01% 441
2024
Q4
Sell
-91
Closed -$30.4K 355
2024
Q3
$30.4K Hold
91
0.01% 273
2024
Q2
$25K Hold
91
0.01% 305
2024
Q1
$31K Hold
91
0.02% 128
2023
Q4
$29.4K Hold
91
0.02% 131
2023
Q3
$33K Buy
91
+9
+11% +$3.47K 0.01% 241
2023
Q2
$31K Buy
82
+57
+228% +$23.2K 0.01% 265
2023
Q1
$12 Hold
25
﹤0.01% 245
2022
Q4
$11K Hold
25
0.01% 229
2022
Q3
$10K Buy
25
+9
+56% +$4.49K 0.01% 334
2022
Q2
$9K Hold
16
0.01% 245
2022
Q1
$9K Buy
+16
New +$9.64K 0.01% 244

Other funds holding BIO

Strengthening Families & Communities LLC's BIO Position: Q2 2026 in Review

Strengthening Families & Communities LLC increased its Bio-Rad Laboratories Class A (BIO) stake by 38% in Q2 2026, buying an estimated $1.7K and bringing the position to 22 shares worth $6.46K. The position accounts for ﹤0.01% of the portfolio, ranked #442.

Strengthening Families & Communities LLC first reported a position in BIO in Q1 2022 and has held it in 15 quarters since. The position peaked at $33K in Q3 2023. 397 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Strengthening Families & Communities LLC held 22 shares of Bio-Rad Laboratories Class A worth $6.46K as of Q2 2026.
  • Strengthening Families & Communities LLC bought 6 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $1.7K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Strengthening Families & Communities LLC's portfolio in Q2 2026, its #442 holding.
  • Strengthening Families & Communities LLC first reported a position in Bio-Rad Laboratories Class A in Q1 2022 and has held it in 15 quarters since.
  • Strengthening Families & Communities LLC's Bio-Rad Laboratories Class A position peaked at $33K in Q3 2023.
  • 397 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Strengthening Families & Communities LLC's 13F filing for Q2 2026, filed 11 Aug 2026.